Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chemotherapy
Researchers report details of new studies and findings in the area of chemotherapy
January 19th, 2006
Chemotherapy data are the focus of recent research from Netherlands, Italy and United Kingdom. Study 1: First-line doxorubicin and docetaxel (AT) was deemed effective in patients with metastatic breast cancer (MBC). In a recent report published in the Journal of Clinical Oncology, researchers in the Netherlands described a study conducted "to compare the efficacy and safety of AT with fluorouracil, doxorubicin, and cyclophosphamide (FAC) as first-line chemotherapy for MBC." "Patients (n=216) were randomly assigned to either AT (doxorubicin 50 mg/m2 and docetaxel 75 mg/m2) or FAC (fluorouracil 500...
Source: Women's Health Weekly (2006-01-19)
|
